SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...

A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a ...

Novel hybrid polymer nanocarriers enable effective vaccine delivery in the lungs and the targeted activation of immune cells.

From lingering coughs to silent breathing disorders, childhood lung problems are more common and more manageable than many ...

Respiratory infections are among the leading causes of illness and death in the elderly, driven by immune aging, chronic ...

Some antibiotics stop bacteria from growing without actually killing them, allowing infections to return later. Scientists at ...

Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...

Doctors at India TV's Pollution Ka Solution Conclave warn that rising air pollution is acting like a slow poison for pregnant ...

The TellDx CTC iChip platform enables high-efficiency isolation of intact circulating tumor cells without reliance on cell size or epithelial markers. This unbiased approach is particularly well ...

First randomized Phase III trial confirming the efficacy of MET inhibition in patients with advanced NSCLC and acquired MET amplification after progression on prior EGFR-TKI treatment - ...

BioNTech's gotistobart receives FDA orphan drug designation, showing promise in improving survival for patients with squamous ...